Lv31
286 积分 2021-03-02 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
25天前
已完结
PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors
26天前
已完结
Interleukin-2–based therapies in cancer
28天前
已完结
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool
29天前
已完结
CD8αα and CD8αβ: truly different?
29天前
已完结
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design
1个月前
已完结
Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity
1个月前
已完结
Dual Targeting of ENPP3 and SIRPα with a Bispecific Antibody Enhances Macrophage-Mediated Immunity in Renal Cell Carcinoma
2个月前
已完结
Advancing targeted protein degradation for cancer therapy
3个月前
已完结
Molecular expression of Ly6k, a putative glycosylphosphatidyl-inositol-anchored membrane protein on the mouse testicular germ cells
3个月前
已关闭
皖公网安备34019202002308
